We defined a case as onset from January 1 to October 31, 2007, of bilateral flaccid paraparesis or paraplegia or retention and incontinence of stool or urine, in a patient receiving intrathecal drugs.
Aug. 2, 2002 -- Prophylactic intrathecal methotrexate significantly reduced recurrence and improved survival for patients in complete remission from aggressive non-Hodgkin's lymphoma (NHL), according ...
“Trying to Be a Good Parent” As Defined By Interviews With Parents Who Made Phase I, Terminal Care, and Resuscitation Decisions for Their Children In this multisite study, 171 children with ...
We describe the clinical spectrum of IT MTX-related SLS, reported in detail in 31 patients treated as part of the UKALL 2003 trial. Concomitant administration of IV cyclophosphamide and cytosine ...
NEW ORLEANS — A study with the worthwhile goal of attempting to further improve outcomes and reduce toxicity of treatment for children and young adults with acute lymphoblastic leukemia (ALL) or ...
Between 1993 and 1999, 1395 children with ALL (778 boys, 617 girls) were enrolled in the FRALLE 93 study. Informed consent was obtained from all patients’ parents in accordance with national ethic ...
Methotrexate 25mg/mL; soln for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection or ...
Accord Healthcare, a London-based drugmaker, resumed manufacturing of two methotrexate solutions, according to a Nov. 7 update from the FDA. By March, the American Society of Health-System Pharmacists ...
Methotrexate 1g/vial; pwd for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results